| Literature DB >> 33582700 |
Tianjiao Lin1, Jingyu Song1, Xinting Pan1, Youdong Wan1, Ziqian Wu1, Shaoyan Lv1, Liangyu Mi1, Yunyun Wang1, Fei Tian1.
Abstract
BACKGROUND Intestinal injury plays a key role in the pathogenesis of severe acute pancreatitis (SAP). In this study, we investigated the protective function of downregulated Gasdermin D (GSDMD) in intestinal damage in a mouse model of severe acute pancreatitis (SAP). MATERIAL AND METHODS Twenty-four healthy male C57BL/6 mice were randomly divided into 4 groups - the NS group, the siRNA-NS group, the SAP group, and the siRNA-SAP group - with 6 mice in each group. SAP was induced in mice by intraperitoneal injection of caerulein and lipopolysaccharide. The pathological changes of pancreatic and the intestinal mucosa and the relative gene and protein expressions in each group were compared, and the levels of GSDMD and serum IL-1ß and IL-18 were evaluated after induction of the SAP model. RESULTS The mice in the SAP group were in more serious condition than those in the siRNA-SAP group, with various degrees of edema and hemorrhage in the intestinal tract. Under an optical microscope, the pathological changes of pancreatic tissue such as edema, inflammatory cell infiltration, and the damage of lobular structural were gradually increased in the SAP group and the siRNA-NS group. In addition, intestinal mucosal damage and intestinal villus breakage were found in the SAP group and the siRNA-NS group, and the latter was lighter than the former. Compared with the SAP group, the level of GSDMD protein expression in the siRNA-SAP group was lower, and the serum levels of IL-1ß and IL-18 were higher in the SAP group and siRNA-SAP group (P<0.05). Immunohistochemical analysis showed the occludin and ZO-1 proteins in the NS group had a strong brown linear signal, while the brown-positive signals were weaker in the siRNA-SAP group and the SAP group. CONCLUSIONS Downregulating GSDMD protein can reduce pancreatitis associated with pyroptosis.Entities:
Mesh:
Substances:
Year: 2021 PMID: 33582700 PMCID: PMC7891845 DOI: 10.12659/MSM.927968
Source DB: PubMed Journal: Med Sci Monit ISSN: 1234-1010
Figure 1Pathological changes of pancreas and intestine in mice and quantitative analysis. (A) Pathological changes of pancreas in mice (HE×200). (B) Pathological changes of intestine in mice (HE×200). (C) Quantitative analysis of pancreatic pathological score. (D) Quantitative analysis of intestinal pathological score. * P<0.05 vs SAP group; # P<0.05 vs NS group
Figure 2Analysis of fluorescence quantitative results of long non-coding uc.173. (A) Real-time amplification curve and product dissolution curve of long non-coding RNA UC.173. (B) Real-time amplification curve and product dissolution curve of actin. (C) Relative quantitative analysis of uc.173. * P<0.05 vs SAP group; # P<0.05 vs NS group
Figure 3The expression of GSDMD-N and serum levels of IL-1β and IL-18. (A) The expression of GSDMD-N in the intestine. (B) Quantitative analysis of serum IL-1β. (C) Quantitative analysis of serum IL-1. * P<0.05 vs SAP group; # P<0.05 vs NS group.
Figure 4Immunohistochemical staining to detect occludin protein and ZO-1 and quantitative scoring in intestinal tissue of mice. (A) Immunohistochemical staining was performed on ileum sections to detect occludin. Original magnification (×200). (B) Immunohistochemical staining was performed on ileum sections to detect ZO-1 (×200). (C) Quantitative analysis of occludin. (D) Quantitative analysis of ZO-1. * P<0.05 vs SAP group; # P<0.05 vs NS group.